Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures. [electronic resource]
Producer: 20180613Description: 529-535 p. digitalISSN:- 1872-7913
- Aged
- Amphotericin B -- therapeutic use
- Antifungal Agents -- therapeutic use
- Aspergillus -- drug effects
- Clinical Decision-Making
- Critical Illness
- Delayed Diagnosis -- mortality
- Drug Therapy, Combination
- Echinocandins -- therapeutic use
- Female
- Fungal Proteins -- therapeutic use
- Humans
- Intensive Care Units
- Invasive Pulmonary Aspergillosis -- diagnosis
- Male
- Middle Aged
- Prognosis
- Respiratory System -- microbiology
- Treatment Outcome
- Voriconazole -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.